#HemOnc
LightNews LightNews
vjhemonc.bsky.social
We recently spoke with Pankit Vachhani, who discussed the potential of MDM2 inhibitors for treating MPNs, outlining the encouraging results observed to date with the MDM2 inhibitor navtemadlin.

Click here to watch:

🎥 buff.ly/cBf3tFe

#MPNsm #HemOnc #BloodSky #HemeSky #MedSky
October 7, 2025 at 12:02 PM
binaytara.bsky.social
Don't miss our upcoming CME/MOC/ACPE-accredited conferences in your region! Connect, learn, and collaborate with leading oncologists and healthcare professionals. Registration is just one click away: buff.ly/4NZ4dNm #Medsky #HemOnc #CMEConferences #Oncology #MedEd
September 26, 2025 at 8:19 PM
vjhemonc.bsky.social
Today is the day – the EHA-EBMT 7th European CAR T-cell Meeting is kicking off in Strasbourg, France!🇫🇷

We are on our way & will be onsite tomorrow to bring you the latest updates from the meeting on VJHemOnc.com!🎥

#CARTCell #CART25 #HemOnc
February 6, 2025 at 8:00 AM
vjhemonc.bsky.social
We had a great time interviewing leading #Myeloma experts & researchers at the 5th Oxford Myeloma Workshop last week!😁🩸

Don't forget to check out our coverage of the event here:
👉 https://buff.ly/40ISfms

Stay tuned for more soon!

#MMSM #MultipleMyeloma #HemOnc #ImmunoOnc #BloodSky #HemeSky
February 5, 2025 at 2:00 PM
vjhemonc.bsky.social
#ASH24 | It was great to interview Vaishali Sanchorawala, who presented the updated results of the ANDROMEDA trial of dara + CyBorD vs CyBorD alone in AL #Amyloidosis.

Watch here:
👉 https://buff.ly/4glJhBr 👈

#HemOnc #ImmunoOnc #CTSM #TrialUpdate @ash.hematology.org
February 1, 2025 at 5:00 PM
vjhemonc.bsky.social
Are in vivo genome editing methods for targeting T-cells the future of CAR-T?🧬

What are some of their benefits, and what challenges remain?

Hear from Dr William Nyberg in a recent interview from #CART25:

🎥 buff.ly/E146kjE

#ImmunoOnc #HemOnc #CARTCell #BloodSky
March 15, 2025 at 1:00 PM
vjhemonc.bsky.social
#MyelomaMRD2025 | Don't miss our recent discussion to learn about novel technologies being explored for MRD detection in #myeloma from experts Benjamin Diamond, David Coffey & Hans Lee!

Click here to watch:

👉 buff.ly/5vuVLdM 👈

#mmMRD #MMsm #HemOnc #BloodSky #HemeSky #MedSky
May 14, 2025 at 1:05 PM
vjhemonc.bsky.social
Watch our recent interview with Jae Park of @mskcancercenter.bsky.social to hear about the long-term data with obe-cel in ALL & its potential to serve as a standalone treatment for adult R/R B-ALL.

Click here:

👉 buff.ly/inx0gbp

#ALLsm #Leusm #Leukemia #CTSM #CARTCell #ImmunoOnc #HemOnc
August 1, 2025 at 4:42 PM
vjhemonc.bsky.social
The MPN Workshop of the Carolinas aims to provide up-to-date information about the pathogenesis & management of MPNs to practicing clinicians & to foster discussion to improve outcomes for patients.🩸

Register for the in-person event or the webinar here:
👉 buff.ly/tiCjJPk

#MPNsm #HemOnc #BloodSky
July 21, 2025 at 3:06 PM
binaytara.bsky.social
Join the CME-accredited 2026 Northern California Hematology Oncology Conference, where Dr. Deepti Behl, Dr. Dron Gauchan, and other leading experts will share their insights on recent updates in #hematology and #oncology: buff.ly/17Co79x #medsky #hemonc #cmeconferences
October 27, 2025 at 10:24 PM
vjhemonc.bsky.social
Join us for our Post-ASH 2024 Highlights starting NEXT WEEK!🔬🩸

Presentations & discussions on selected abstracts from
#ASH24

Unpack groundbreaking findings & join the conversation with leading #HemOnc experts 🔦

REGISTER NOW 👉 buff.ly/4hMI6Nr

#Hematologynews #MedicalEducation #VJHemOnc
January 15, 2025 at 12:43 PM
megan2wheels.bsky.social
Has anyone been tracking his height and weight? -Yes, assiduously, at the HEMONC clinic.

Has he had any recent bloodwork done? -Yes, he gets a full workup every month at his HEMONC checkup.
November 22, 2024 at 10:06 PM
vjhemonc.bsky.social
#CART25 | Christian Chabannon shares updates on ongoing projects of the #GoCARTcoalition!

Click here to watch the interview:
👉 buff.ly/4hSG1Po 👈

#ImmunoOnc #HemOnc #CARTCell #Hematology #MedSky #BloodSky #HemeSky
February 25, 2025 at 1:46 PM
vjhemonc.bsky.social
Catch up on the latest breakthroughs in #HemOnc with our expert-led Post-#EHA2025 Highlights webinars 💻📍

🔗 REGISTER 👉 vjhemonc.com/event/post-e...

#VJHemOnc
May 29, 2025 at 9:17 AM
vjhemonc.bsky.social
#iwMPN25 | Alexander Lyon discusses cardiovascular health in patients with MPNs, and provides insight into risk stratification & management strategies.🫀🩸

Click here to watch the interview:

👉 buff.ly/CxamPIw 👈

#MPNsm #HemOnc #BloodSky #HemeSky #MedSky
July 23, 2025 at 8:01 AM
vjhemonc.bsky.social
Check out this week's podcast!🎙️

Featuring Marlise Luskin, Nicole LeBoeuf, and Shai Shimony, who share insights into BPDCN from a hematology and dermatology perspective.

🎧 Listen here: https://buff.ly/3ZxE0S6

#HemOnc #Leusm #MPNsm
December 2, 2024 at 12:35 PM
binaytara.bsky.social
#HemOnc Fellows! Get real-world insights beyond fellowship training at #HemeLA25 on Mar 28-29! Register NOW: buff.ly/Asb0RAu @ucsfhealth.bsky.social @ucirvine.bsky.social @ucdavishealth.bsky.social @ucsdmedschool.bsky.social @stanfordmedicine.bsky.social @theaacr.bsky.social @ascocancer.bsky.social
March 6, 2025 at 11:52 PM
vjhemonc.bsky.social
We just had a great discussion with Dr Curtis Lachowiez and Prof. Daniel Pollyea on mechanisms of venetoclax resistance in AML and strategies being explored to overcome them🩸🔬

Stay tuned on vjhemonc.com for this exclusive session!

#ISAL2025 #HemOnc #AML #Leukemia
March 17, 2025 at 1:18 PM
vjhemonc.bsky.social
FLT3 inhibitors are revolutionizing the management of patients with AML.

Watch our interview with Naval Daver, MD of The University of Texas MD Anderson Cancer Center to gain valuable insight into this!🎥

Click here:
👉 https://buff.ly/4eEPwzk 👈

#AMLsm #Leusm #SOHO2024 #Leukemia #HemOnc
November 19, 2024 at 9:29 AM
vjhemonc.bsky.social
Welcome!👋🧡

We are a global, open access, expert-led video journal bringing healthcare professionals trustworthy, cutting-edge updates in #HemOnc🔦

🩸Disease areas www.vjhemonc.com/subjects/#all

🎧VJHemOnc Podcast www.vjhemonc.com/podcasts/

📩VJHemOnc Newsletter www.vjhemonc.com/newsletter/
November 18, 2024 at 11:50 AM
vjhemonc.bsky.social
#18ICML | Neil Berinstein of @sunnybrookhsc.bsky.social shares updates from the BRAWM trial, which is evaluating the combination of bendamustine, rituximab, & acalabrutinib in Waldenström’s macroglobulinemia:

🎥 buff.ly/svYBGt2

#LYMsm #Lymphoma #RareDisease #HemOnc #ImmunoOnc #CTSM #TrialUpdate
August 7, 2025 at 9:01 AM
vjhemonc.bsky.social
At #EBMT25, Aldo Acosta-Medina shared insights into the clinical outcomes and treatment strategies for TA-TMA, outlining findings from the largest cohort of adult patients with TA-TMA to date!

Learn more by watching here:

👉 buff.ly/FPPGd6Z

#BMTsm #HemOnc #BloodSky #HemeSky #MedSky
April 26, 2025 at 3:02 PM
vjhemonc.bsky.social
In an interview from #ASH24, Sabina Chiaretti comments on the efficacy and tolerability of frontline ponatinib + blinatumomab for adult patients with Ph+ ALL, which was studied in the GIMEMA ALL2820 trial:

👉 https://buff.ly/3WPn0VD

#ALLsm #Leusm #CTSM #HemOnc #ImmunoOnc @ash.hematology.org
February 12, 2025 at 11:04 AM
jameabraham.bsky.social
We are excited to welcome Dr. Santhosh Rao as the Medical Director of the HemOnc team @ClevelandClinic Akron General! In addition to general oncology - he will be focusing on building a Genito Urinary Medical Oncology Program in @ClevelandClinic Southern Market
August 9, 2025 at 11:33 AM
vjhemonc.bsky.social
We've had so many fantastic conversations at #EBMT25 already, and we have a whole day of interviews left to go!😁

Missed out on the meeting? Not to worry!
We'll be sharing exclusive updates with you on 👉 VJHemOnc.com 👈

#BMTsm #ImmunoOnc #HemOnc #Hematology #MedSky #BloodSky #HemeSky
April 1, 2025 at 6:30 AM